Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Heart Rhythm|February 9, 2024
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trialReinoud E Knops, Mikhael F El-Chami, Christelle Marquie, et al.
Circulation|April 25, 2026
Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT TrialReinoud E Knops, Christelle Marquie, Peter Nordbeck, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 14, 2021
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac deathTom E Verstraelen, Marit van Barreveld, Pascal H F M van Dessel, et al.
JAMA Neurology|October 7, 2024
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite AnticoagulationMoniek Maarse, David J Seiffge, David J Werring, et al.
Thrombosis Research|November 15, 2025
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED scoreS F B van der Horst, G Chu, J Seelig, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Circulation. Arrhythmia and Electrophysiology|December 3, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN TrialLouise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, et al.
European Heart Journal|August 28, 2022
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trialReinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, et al.
Pageof 25